Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway

Author:

Zhang Liangyu1,Fu Zelong2,Li Xia34,Tang Haitao5,Luo Jiesi4,Zhang Dehui1,Zhuang Yongzhi1,Han Zhiyang6ORCID,Yin Mingzhu34

Affiliation:

1. Department of Oncology; Daqing Oil Field General Hospital; Daqing City China

2. Department of Breast surgery; Tianjin Central Obstetrics and Gynecology Hospital; Tianjin City China

3. Hunan Key Laboratory of Skin Cancer and Psoriasis; Xiangya Hospital; Central South University; Changsha Hunan China

4. Yale Stem Cell Center; Yale University; New Haven CT USA

5. Department of Neurosurgery; Daqing Oil Field General Hospital; Daqing City China

6. Department of General Surgery; The First Affiliated Hospital of Harbin Medical University; Harbin China

Funder

Program of Young Innovative Scientists for Provincial Universities in Heilongjiang, China

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3